Andrew Perlman
MANAGING DIRECTOR & CHIEF MEDICAL OFFICER
Clinical Research
Velocity Pharmaceutical Development
United States of America
Biography
Andy has had a notable career in drug development, most significantly at Genentech from 1988 to 1993, where as Senior Director of Clinical Research he played a key role in the development, FDA approval and marketing of human growth hormone (hGH, Nutropin). He was also responsible for the development of Genentech's entire portfolio of endocrine drugs and drug candidates. In addition, he also maintained a research lab at Genentech and was a member of the team responsible for evaluation and selection of new therapeutic drug candidates.
Research Interest
business development, investor relations and financing activities
